Merck Offers $9.2bn To Buy Cidara And Phase III Antiviral Flu Preventative

 
• By Joseph Haas
  
Elderly
Merck will pay $9.2bn to acquire Cidara and its antiviral flu preventative • Source: Shutterstock

More from Deals

More from Business